Clarus Therapeutics Holdings, Inc. Announces Completion of Auction for Sale of JATENZO® and Selection of Tolmar, Inc. as Successful Bidder
Court-supervised auction for JATENZO (testosterone undecanoate capsules; C-III) concluded on October 14, 2022 NORTHBROOK, Ill., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdings, Inc. (
Testosterone Drug Maker Clarus Files For Bankruptcy -- Market Talk
1534 ET - Publicly traded Clarus Therapeutics Holdings, the maker of testosterone drug Jatenzo, has filed for chapter 11 bankruptcy, saying it has missed its sales targets and been unable to meet its
Clarus Files for Chapter 11 Bankruptcy, Eyes Auction of Testosterone Therapy Jatenzo
Clarus Therapeutics (OTCPK:CRXT) filed voluntary petitions under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware and want to pursue an auction and sale of its only commercial asse
Clarus Therapeutics: Jatenzo Auction Projected to End in Late October >CRXT
Clarus Therapeutics: Jatenzo Auction Projected to End in Late October >CRXT
Clarus Therapeutics Seeks Authorization to Pursue Auction, Sale Process for Sole Commercial Asset Jatenzo >CRXT
Clarus Therapeutics Seeks Authorization to Pursue Auction, Sale Process for Sole Commercial Asset Jatenzo >CRXT
Clarus Therapeutics Files Voluntary Petitions Under Chapter 11 >CRXT
Clarus Therapeutics Files Voluntary Petitions Under Chapter 11 >CRXT
Clarus Therapeutics Holdings, Inc. Announces Plan for Near-Term Sale of JATENZO® Using Structured Process Through Chapter 11 of the U.S. Bankruptcy Code
Bidding process and auction for JATENZO (testosterone undecanoate capsules; C-III) projected to conclude late October 2022NORTHBROOK, Ill., Sept. 05, 2022 (GLOBE NEWSWIRE) -- Clarus Therapeutics Hol
Why Nikola Dropped Over 9%; Here Are 66 Biggest Movers From Yesterday
Gainers Mobile Global Esports Inc. (NASDAQ:MGAM) shares surged 103.9% to settle at $5.30 on Tuesday. Shares are in low-float territory; the issue has about 15 million shares in its float.NewAge, Inc.
Why IN8bio Is Trading Higher By 46%, Here Are 54 Stocks Moving In Tuesday's Mid-Day Session
Gainers NewAge, Inc. (NASDAQ:NBEV) rose 54.4% to $0.3220.IN8bio, Inc. (NASDAQ:INAB) jumped 46% to $2.89 after a Form 4 Filing showed Cavu Advisors purchased 51,214 shares at an average price of $2.02.
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 250 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows: Toyota Motor (NYSE:TM) was the biggest company on a market cap basis to set a new 52-week low.SciSparc (N
Why Baudax Bio Is Trading Lower By 34%; Here Are 26 Stocks Moving Premarket
Gainers Mobile Global Esports Inc. (NASDAQ:MGAM) shares rose 28.1% to $3.33 in pre-market trading after gaining over 5% on Monday. The company recently reported an exclusive compression technology par
Why Bed Bath & Beyond Jumped Around 25%; Here Are 68 Biggest Movers From Yesterday
Gainers American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) climbed 156.3% to close at $0.3750 on Monday. American Virtual Cloud Technologies shares gained around 8% on Friday after the company a
Clarus Therapeutics Shares Are Trading Lower After the Company Announced It Has Received a Non-compliance Letter From Nasdaq. The Shares Will Be Suspended on August 31st and Will Begin Trading on the OTC Pink Market.
Clarus Therapeutics shares are trading lower after the company announced it has received a non-compliance letter from Nasdaq. The shares will be suspended on August 31st and will begin trading on the
Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXTW) Short Interest Update
Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXTW – Get Rating) saw a large decrease in short interest in the month of August. As of August 15th, there was short interest totalling 13,500 shares, a d
Top Premarket Decliners
07:51 AM EDT, 08/29/2022 (MT Newswires) -- Clarus Therapeutics (CRXT) shares slumped more than 33%, adding to Friday's losses. Jianzhi Education (JZ) shares tumbled 23%, paring Friday's rally. Sunrise
Why Hill International Is Trading Higher By 15%; Here Are 30 Stocks Moving Premarket
Gainers NewAge, Inc. (NASDAQ:NBEV) shares rose 19.7% to $0.2432 in pre-market trading. NewAge recently received Nasdaq notice on late filing of its form 10-Q.Bright Minds Biosciences Inc. (NASDAQ:DRUG
Reviewing Clarus Therapeutics (NASDAQ:CRXT) & Ayala Pharmaceuticals (NASDAQ:AYLA)
Ayala Pharmaceuticals (NASDAQ:AYLA – Get Rating) and Clarus Therapeutics (NASDAQ:CRXT – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two c
Clarus Therapeutics (NASDAQ:CRXT) Downgraded by Maxim Group
Maxim Group downgraded shares of Clarus Therapeutics (NASDAQ:CRXT – Get Rating) from a buy rating to a hold rating in a research report sent to investors on Monday morning, The Fly reports. A number
Clarus Therapeutics (NASDAQ:CRXT) Lowered to Hold at Needham & Company LLC
Needham & Company LLC cut shares of Clarus Therapeutics (NASDAQ:CRXT – Get Rating) from a buy rating to a hold rating in a research report report published on Tuesday, The Fly reports. CRXT has b
Clarus Therapeutics Cut to Hold From Buy by Needham
Clarus Therapeutics Cut to Hold From Buy by Needham
No Data